A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs

For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been attempted with overlooked or overestimated efficacy owing to limited clinical evidence. Most early clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Po-Lin, Lee, Nan-Yao, Cia, Cong-Tat, Ko, Wen-Chien, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751753/
https://www.ncbi.nlm.nih.gov/pubmed/33364959
http://dx.doi.org/10.3389/fphar.2020.584956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751753/
https://www.ncbi.nlm.nih.gov/pubmed/33364959
http://dx.doi.org/10.3389/fphar.2020.584956

Ejemplares similares